Works by Hui, Zhao


Results: 4647
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24

    Meplazumab, a CD147 antibody, for severe COVID-19: a double-blind, randomized, placebo-controlled, phase 3 clinical trial.

    Published in:
    Signal Transduction & Targeted Therapy, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41392-025-02208-9
    By:
    • Bian, Huijie;
    • Chen, Liang;
    • Zhang, Zheng;
    • Wen, Ai-Dong;
    • Zheng, Zhao-Hui;
    • Song, Li-Qiang;
    • Yao, Meng-Ying;
    • Liu, Ying-Xia;
    • Zhang, Xi-Jing;
    • Dong, Hong-Lin;
    • Lian, Jian-Qi;
    • Pan, Lei;
    • Liu, Yu;
    • Gu, Xing;
    • Zhao, Hui;
    • Wang, Jing-Wen;
    • Wang, Qing-Yi;
    • Zhang, Kui;
    • Jia, Jun-Feng;
    • Xie, Rong-Hua
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50